This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hsu, P.-L. Articles by Hsu, S.-M. Search for Related Content PubMed PubMed Citation Articles by Hsu, P.-L. Articles by Hsu, S.-M.

Identification of an M_r 70,000 Antigen Associated with Reed-Sternberg Cells and Interdigitating Reticulum Cells

Department of Pathology, University of Texas Health Science Center at Houston, Houston, Texas 77030

We obtained a monoclonal antibody that has restricted reactivity with tumor cells [Hodgkin's mononuclear cells and Reed-Sternberg (H-RS) cells in Hodgkin's disease by immunizing mice with 12-O-tetradecanoyl phorbol-13-acetate-induced H-RS cells. The antibody, anti-IRac, reacted with H-RS cells in 8 of 20 patients who had Hodgkin's disease, as well as with interdigitating reticulum cells in dermatopathic lymph nodes and with cells of three H-RS cell lines, HDLM-1, L428, and KM-H2. The antigen IRac is a protein of molecular weight 70,000 which we found to have the following properties. (a) After 12-O-tetradecanoyl phorbol-13-acetate induction, the expression of IRac was decreased slightly in HDLM and L428 cells but increased in KM-H2. This is in contrast to a rapid decrease in the expression of two other H-RS-cell-associated antigens, CD30 and 2H9, in all 12-O-tetradecanoyl phorbol-13-acetate-treated H-RS cells. Thus, IRac may be associated with H-RS cells at advanced stages of differentiation, and its expression may not be attributable solely to cellular proliferation. (b) IRac was detected rarely in normal or in antigen- or mitogen-activated lymphocytes but was observed frequently in virus-transformed B- or T-lymphocytes. These findings were similar to those with CD30 and 2H9, indicating that the expression of all three of these antigens is probably under a similar regulatory control. (c) IRac was absent from cells in most non-Hodgkin's lymphomas; its expression could not be modulated by treatment of cells with anti-IRac. We conclude that use of IRac could facilitate the diagnosis of Hodgkin's disease and that it may be suitable for immunotherapy or immunoimaging. The expression of IRac in both H-RS cells and interdigitating reticulum cells, along with earlier evidence, indicates that H-RS cells have antigenic and functional similarities to interdigitating reticulum cells or to cells of interdigitating reticulum cell/histiocyte lineage.

¹ To whom requests for reprints should be addressed, at Department of Pathology, P.O. Box 20708, University of Texas, Houston, Texas 77225.

Received 7/27/89. Revised 9/27/89. Accepted 10/13/89.

This article has been cited by other articles:

				H.-D. Foss, R. Reusch, G. Demel, G. Lenz, I. Anagnostopoulos, M. Hummel, and H. Stein Frequent Expression of the B-Cell-Specific Activator Protein in Reed-Sternberg Cells of Classical Hodgkin's Disease Provides Further Evidence for Its B-Cell Origin Blood, November 1, 1999; 94(9): 3108 - 3113. [Abstract] [Full Text] [PDF]

				D. N.J. Hart Dendritic Cells: Unique Leukocyte Populations Which Control the Primary Immune Response Blood, November 1, 1997; 90(9): 3245 - 3287. [Full Text] [PDF]